|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/498 | |
| A61K 31/519 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2056829 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07811344.6 |
| Europos patento paraiškos padavimo data | 2007-08-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-05-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-01-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/018057 |
| Data | 2007-08-16 |
| (87) | Numeris | WO 2008/021389 |
| Data | 2008-02-21 |
| (30) | Numeris | Data | Šalis |
| 838307 P | 2006-08-16 | US |
| (72) |
AFTAB, Dana, T., US
LAIRD, A., Douglas, US
LAMB, Peter, US
MARTINI, Jean-Francois, A., US
|
| (73) |
Exelixis, Inc.,
210 East Grand Avenue, South San Francisco, CA 94080,
US
|
| (54) | USING PI3K AND MEK MODULATORS IN TREATMENTS OF CANCER |
| USING PI3K AND MEK MODULATORS IN TREATMENTS OF CANCER |